| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4124834 | Otolaryngology - Head and Neck Surgery | 2010 | 6 Pages |
Abstract
Usage of TGF-β1 antisense oligodeoxynucleotides (ODNs) may show a potential chemopreventive or therapeutic option for keloids by blocking the effect of TGF-β1. Furthermore, antisense ODNs can be used as an investigative approach toward a better understanding of molecular mechanisms in keloid pathophysiology.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Gregor M. MD, Ulrich R. MD, Ariton Baftiri, Karl MD, Frank MD, Haneen MD,